fda glp-1 warning letters november 2025 warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain Societies take stand against off-brand

A survey conducted in August found that more than 80% of Americans had heard at least a little bit about semaglutide, while about one-third had either tried it or expressed interest in doing so

He noted Highmark has hired 1,800 new associates year-to-date

However, some patients experience persistent nausea, vomiting, or constipation and benefit from extended intervals between dose increases5 or 6 weeks rather than 4

For patients with obesity the population GLP-1s are prescribed to relative muscle mass and the strength-to-weight ratio may matter more than the absolute numbers that drive the Batsis benchmark

Semaglutide commonly causes nausea, vomiting, diarrhea, and constipation, particularly during dose escalation